Short Interest in AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Rises By ∞

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) was the target of a large growth in short interest in August. As of August 14th, there was short interest totaling 417,214 shares, a growth of ∞ from the July 30th total of 0 shares. Based on an average daily volume of 1,423,228 shares, the days-to-cover ratio is currently 0.3 days.

AXIM Biotechnologies Stock Performance

Shares of AXIM Biotechnologies stock traded up $0.00 on Friday, hitting $0.00. 194,365 shares of the company were exchanged, compared to its average volume of 291,313. AXIM Biotechnologies has a 1-year low of $0.00 and a 1-year high of $0.03.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc is a development-stage biotechnology company focused on the research, development and commercialization of cannabinoid-based technologies. The company’s primary objective is to advance formulations and delivery systems for cannabidiol (CBD) and other cannabinoids, targeting applications in nutraceuticals, skincare and medical devices. Through its proprietary encapsulation and atomization techniques, AXIM aims to enhance the bioavailability and stability of cannabinoid compounds for consumer and clinical use.

The company’s product pipeline includes novel CBD-infused nutraceuticals designed to promote general wellness, as well as specialized formulations for topical and inhalation delivery.